@article{3182163,
    title = "Results of the Pivotal STORM Study (Part 2) in Penta-Refractory Multiple
Myeloma (MM): Deep and Durable Responses with Oral Selinexor Plus Low
Dose Dexamethasone in Patients with Penta-Refractory MM",
    author = "Chari, Ajai and Vogl, Dan T. and Dimopoulos, Meletios A. and Nooka, Ajay and K. and Huff, Carol Ann and Moreau, Philippe and Cole, Craig E. and and Richter, Joshua and Dingli, David and Vij, Ravi and Tuchman, Sascha A. and and Raab, Marc S. and Weisel, Katja and Delforge, Michel and Kaminetzky, and David and Cornell, Robert Frank and Stewart, A. Keith and Hoffman, James and and Godby, Kelly N. and Parker, Terri L. and Levy, Moshe and Schreder, and Martin and Meuleman, Nathalie and Frenzel, Laurent and Mohty, Mohamad and and Sylvain, Choquet and Yee, Andrew J. and Gavriatopoulou, Maria and and Costa, Luciano J. and Shah, Jatin J. and Picklesimer, Carla and and Saint-Martin, Jean-Richard and Li, Lingling and Kauffman, Michael G. and and Shacham, Sharon and Richardson, Paul and Jagannath, Sundar",
    journal = "Blood advances",
    year = "2018",
    volume = "132",
    number = "1",
    publisher = "AMER SOC HEMATOLOGY",
    doi = "10.1182/blood-2018-99-116663"
}